Development of a high-performance thin-layer chromatography method for the rapid quantification of S-equol in biological samples of albino Wistar rats

[1] Axelson M(1982)The identification of the weak oestrogen equol [7-hydroxy-3-(4'-hydroxyphenyl)chroman] in human urine Biochem J 201 353-357

[2] Kirk DN(2002)The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones J Nutr 132 3577-3584

[3] Farrant RD(2007)Metabolism of dietary soy isoflavones to equol by human intestinal microflora: implications for health Mol Nutr Food Res 51 765-781

[4] Cooley G(2014)Daidzein, R-(+)equol and S-(-)equol inhibit the invasion of MDA-MB-231 breast cancer cells potentially via the down-regulation of matrix metalloproteinase-2 Eur J Nutr 53 345-350

[5] Lawson AM(2004)Equol is a novel anti-androgen that inhibits prostate growth and hormone feedback Biol Reprod 70 1188-1195

[6] Setchell KD(2003)Bioavailability of soybean isoflavones from aglycone and glucoside forms in American women Am J Clin Nutr 77 1459-1465

[7] Setchell KDR(2009)Stereospecific biotransformation of dihydrodaidzein into (3S)-equol by the human intestinal bacterium Appl Environ Microbiol 75 3062-3068

[8] Brown NM(2005) strain Julong 732 Am J Clin Nutr 81 1072-1079

[9] Lydeking-Olsen E(1998)S-equol, a potent ligand for estrogen receptor β, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora Proc Soc Exp Biol Med 217 300-309

[10] Yuan P(2004)The effective free fraction of estradiol and xenoestrogens in human serum measured by whole cell uptake assays: physiology of delivery modifies estrogenic activity Bioorg Med Chem 12 1559-1567

[1] Axelson M(1982)The identification of the weak oestrogen equol [7-hydroxy-3-(4'-hydroxyphenyl)chroman] in human urine Biochem J 201 353-357

[2] Kirk DN(2002)The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones J Nutr 132 3577-3584

[3] Farrant RD(2007)Metabolism of dietary soy isoflavones to equol by human intestinal microflora: implications for health Mol Nutr Food Res 51 765-781

[4] Cooley G(2014)Daidzein, R-(+)equol and S-(-)equol inhibit the invasion of MDA-MB-231 breast cancer cells potentially via the down-regulation of matrix metalloproteinase-2 Eur J Nutr 53 345-350

[5] Lawson AM(2004)Equol is a novel anti-androgen that inhibits prostate growth and hormone feedback Biol Reprod 70 1188-1195

[6] Setchell KD(2003)Bioavailability of soybean isoflavones from aglycone and glucoside forms in American women Am J Clin Nutr 77 1459-1465

[7] Setchell KDR(2009)Stereospecific biotransformation of dihydrodaidzein into (3S)-equol by the human intestinal bacterium Appl Environ Microbiol 75 3062-3068

[8] Brown NM(2005) strain Julong 732 Am J Clin Nutr 81 1072-1079

[9] Lydeking-Olsen E(1998)S-equol, a potent ligand for estrogen receptor β, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora Proc Soc Exp Biol Med 217 300-309

[10] Yuan P(2004)The effective free fraction of estradiol and xenoestrogens in human serum measured by whole cell uptake assays: physiology of delivery modifies estrogenic activity Bioorg Med Chem 12 1559-1567